NIH-funded research NIH-funded research

Exploring mitochondrial transplantation for various health conditions

Official title: Mitochondrial Transplantation Conference

Funded at Feinstein Institute for Medical Research · NIH-11074333 · Data updated 2026-11-12

This study is all about bringing together scientists to talk about a new treatment called mitochondrial transplantation, which could help with serious health problems like heart issues, cancer, and obesity, so they can share ideas and work together to make this therapy available for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startApril 1, 2025
Project endMarch 31, 2026
Funding year2025
Award (this year)$20,000
NIH project number1R13HL172577-01A1
Project IDNIH-11074333 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients suffering from conditions like cardiac arrest, cancer, or obesity who may benefit from innovative mitochondrial therapies.

Less likely to help

Patients with stable, non-bioenergetic related conditions may not receive any benefit from this research.

What this research studies

This research focuses on mitochondrial transplantation (MT), a promising new therapy that could help treat a range of serious health issues, including cardiac arrest, cancer, and obesity. The project aims to organize the first-ever conference dedicated to mitochondrial medicine, bringing together researchers and advocates to share findings and foster collaboration. By connecting scientists who have been working in isolation, the conference seeks to accelerate the development of MT as a viable treatment option. Attendees will include leading experts and emerging researchers who will present their latest work and discuss the therapeutic potential of mitochondrial transplantation.

Why it matters

Potential benefit: If successful, this research could lead to groundbreaking therapies that improve outcomes for patients with various bioenergetic conditions.

How similar studies have gone: While mitochondrial transplantation is a relatively novel approach, preliminary results in animal models have shown promise, indicating potential for future human applications.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Becker, Lance B. — Feinstein Institute for Medical Research
  • Study coordinator: Becker, Lance B.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.